txn10128
Small moleculeexperimental
Clinical trial activity
1 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jul 27, 2023 (NCT05978492)
Timeline
2020s
- Jan 1, 2023
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05978492 | Phase 1 | Jul 27, 2023 | Seoul National University, Sungkyunkwan University, Txinno Bioscience Inc., University of Ulsan |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Seoul National University | Academic/Hospital | 1 | 0 | 1 | 2023 |
| Sungkyunkwan University | Academic/Hospital | 1 | 0 | 1 | 2023 |
| Txinno Bioscience Inc. | For profit | 1 | 1 | 1 | 2023 |
| University of Ulsan | Academic/Hospital | 1 | 0 | 1 | 2023 |
4 organizations
Page 1 / 1